Intellectual property
Whether it is having the freedoms or permissions to do what you want to do, protect what you have created or monetise the assets you own, intellectual property (IP), like brands, inventions, business secrets and other know-how, has never been more important.
Osborne Clarke's understanding of national and international IP landscapes, as well as the commercial backdrops, allows our clients to keep up with change.
Article list
Virtual tops, real trademarks: how in the US and Europe to navigate fashion IP in the metaverse
IP basics: what to think about when entering the UK and EU markets (trade marks, copyright, designs)
European Commission proposes harmonisation of patent law with unitary SPCs and single procedure for grant
Debate intensifies over a vaccine IP waiver's impact on future pharma and biotech discoveries
Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?
Coronavirus Legal Briefing | The EU's exit strategy for business
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.
Coronavirus A guide for your business
COVID-19 – and the measures governments have implemented to slow the spread of the virus – represent an unprecedented challenge...
Coronavirus | A guide for your business
The coronavirus represents a unique challenge for businesses playing their part in looking after staff and customers, while continuing to...
The Digital Revolution: The Internet of Things
From opening your garage door with your phone, to fridges that chill your wine to suit the weather, the growth...
Spain draws €194m line in Apple-Amazon brand protection and competition restriction ruling
Virtual tops, real trademarks: how in the US and Europe to navigate fashion IP in the metaverse
IP basics: what to think about when entering the UK and EU markets (trade marks, copyright, designs)
European Commission proposes harmonisation of patent law with unitary SPCs and single procedure for grant
Debate intensifies over a vaccine IP waiver's impact on future pharma and biotech discoveries
Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?
Coronavirus Legal Briefing | The EU's exit strategy for business
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.
Coronavirus A guide for your business
COVID-19 – and the measures governments have implemented to slow the spread of the virus – represent an unprecedented challenge...
Coronavirus | A guide for your business
The coronavirus represents a unique challenge for businesses playing their part in looking after staff and customers, while continuing to...
The Digital Revolution: The Internet of Things
From opening your garage door with your phone, to fridges that chill your wine to suit the weather, the growth...